Shin Kan Selected Research

Shin Kan Research Topics

Disease

22	Neoplasms (Cancer) 05/2016 - 11/2004
5	Wilms Tumor (Wilm's Tumor) 10/2020 - 08/2014
3	Adenocarcinoma 11/2021 - 10/2015
2	Leukemia 01/2017 - 07/2014
2	Breast Neoplasms (Breast Cancer) 07/2015 - 09/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 08/2014
1	Acute Promyelocytic Leukemia 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2016
1	Carcinogenesis 03/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2015
1	Hypersensitivity (Allergy) 08/2014
1	Squamous Cell Carcinoma of Head and Neck 07/2013
1	Carcinoma (Carcinomatosis) 03/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2012
1	Colorectal Neoplasms (Colorectal Cancer) 12/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2011
1	Multiple Myeloma 02/2011
1	Herpes Zoster 02/2011
1	Renal Insufficiency (Renal Failure) 02/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2005
1	Neoplasm Metastasis (Metastasis) 09/2005
1	Fibrosarcoma 11/2004

Drug/Important Bio-Agent (IBA)

7	PicibanilIBA 07/2013 - 11/2004
6	AntigensIBA 01/2015 - 01/2013
4	Peptides (Polypeptides)IBA 10/2020 - 08/2014
4	Cancer VaccinesIBA 01/2019 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2013
4	Gemcitabine FDA Link 05/2016 - 11/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2014 - 10/2005
3	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 10/2005
2	Monoclonal AntibodiesIBA 05/2016 - 10/2015
2	CalreticulinIBA 03/2016 - 01/2013
2	Ado-Trastuzumab EmtansineIBA 10/2015 - 07/2015
2	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 07/2014
2	LipopolysaccharidesIBA 07/2014 - 08/2012
2	VaccinesIBA 09/2013 - 05/2013
2	Ethanol (Ethyl Alcohol)IBA 08/2013 - 01/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2013 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 10/2005
2	Toll-Like Receptor 4IBA 08/2012 - 11/2004
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 08/2012 - 11/2004
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020
1	Sirtuin 2IBA 01/2017
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2017
1	CREB-Binding ProteinIBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Histones (Histone)IBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 05/2016
1	Complement System Proteins (Complement)IBA 05/2016
1	Thrombopoietin ReceptorsIBA 03/2016
1	Immune Checkpoint ProteinsIBA 10/2015
1	MucinsIBA 10/2015
1	Immune Checkpoint InhibitorsIBA 10/2015
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Galectins (Galectin)IBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2015
1	Trastuzumab (Herceptin)FDA Link 07/2015
1	human ERBB2 proteinIBA 07/2015
1	Cytotoxins (Cytolysins)IBA 07/2015
1	EpitopesIBA 08/2014
1	tomato lectinIBA 05/2014
1	HMGB1 Protein (HMG1)IBA 01/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013
1	Penicillins (Penicillin)FDA Link 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	Histocompatibility Antigens Class IIIBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	LigandsIBA 08/2012
1	Caspase 1 (ICE Protease)IBA 08/2012
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Bortezomib (Velcade)FDA Link 02/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2006
1	Acetates (Acetic Acid Esters)FDA Link 05/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2006
1	Arginine (L-Arginine)FDA Link 05/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2005
1	ChemokinesIBA 09/2005
1	2-nitroimidazole acetamideIBA 09/2005
1	titanium silicide (TS-1)IBA 11/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2019 - 11/2004
4	Therapeutics 01/2017 - 11/2004
1	Immunomodulation 09/2014
1	Cryotherapy (Therapy, Cold) 09/2014
1	Radiotherapy 07/2013
1	Immunotherapy 12/2012
1	Oral Administration 11/2004